| 缩写名/全名 |
ONCOL RES TREAT
Oncology Research and Treatment |
||||||||||||||||||||||||
| ISSN号 | 2296-5270 | ||||||||||||||||||||||||
| 研究方向 | ONCOLOGY- | ||||||||||||||||||||||||
| 影响因子 | 2015:1.333, 2016:1.667, 2017:1.494, 2018:1.483, 2019:1.967, | ||||||||||||||||||||||||
| 出版国家 | GERMANY | ||||||||||||||||||||||||
| 出版周期 | |||||||||||||||||||||||||
| 年文章数 | 73 | ||||||||||||||||||||||||
| 出版年份 | 0 | ||||||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||||||
| 审稿周期(仅供参考) | |||||||||||||||||||||||||
| 录用比例 | |||||||||||||||||||||||||
| 投稿链接 | http://www.karger.com/Journal/Guidelines/224106 | ||||||||||||||||||||||||
| 投稿官网 | http://www.karger.com/Journal/Home/224106 | ||||||||||||||||||||||||
| h-index | 43 | ||||||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2296-5270%5BISSN%5D | ||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Body Mass Index at Diagnosis as a Prognostic Factor for Early-Stage Invasive Breast Cancer after Surgical Resection. Author: Wang X1, Hui TL1, Wang MQ1, Liu H1, Li RY1, Song ZC2. Journal: Oncol Res Treat. 2019;42(4):195-201. doi: 10.1159/000496548. Epub 2019 Mar 8. PubMed DOI |
| 2. | Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer. Author: Peng P1, Chen T2, Wang Q3, Zhang Y4, Zheng F5, Huang S6, Tang Y7, Yang C8, Ding W1, Ren D9, Huang Z10, Guo Y2. Journal: Oncol Res Treat. 2019;42(4):165-185. doi: 10.1159/000495473. Epub 2019 Mar 14. PubMed DOI |
| 3. | A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer. Author: Cheng M1, Song Z2, Qi Y2, Wang X2, Zhang L2, Shi J2, Wang M3. Journal: Oncol Res Treat. 2019;42(5):269-274. doi: 10.1159/000498993. Epub 2019 Apr 3. PubMed DOI |
| 4. | Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies. Author: Li W1,2, Xu L3. Journal: Oncol Res Treat. 2019 May 3:1-9. doi: 10.1159/000498947. [Epub ahead of print] PubMed DOI |
| 5. | The Value of COX-2, NF-κB, and Blood Routine Indexes in the Prognosis of Malignant Peritoneal Mesothelioma. Author: Yin W1, Zheng G2, Su S1, Liang Y1. Journal: Oncol Res Treat. 2019 May 7:1-8. doi: 10.1159/000499677. [Epub ahead of print] PubMed DOI |
| 6. | Quantitative Multiparametric MRI May Augment the Response to Radiotherapy in Mid-Treatment Assessment of Patients with Esophageal Carcinoma. Author: Xie T1, Ye Z2, Pang P3, Shao G4. Journal: Oncol Res Treat. 2019 May 7:1-8. doi: 10.1159/000499322. [Epub ahead of print] PubMed DOI |
| 7. | Comparisons of Cardiotoxicity and Efficacy of Anthracycline-Based Therapies in Breast Cancer: A Network Meta-Analysis of Randomized Clinical Trials. Author: Mao Z1, Shen K1, Zhu L1, Xu M2, Yu F3, Xue D4, Li H1, Xue C5. Journal: Oncol Res Treat. 2019 May 17:1-9. doi: 10.1159/000500204. [Epub ahead of print] PubMed DOI |
| 8. | Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China. Author: Liang R, Wang Z, Bai QX, Gao GX, Yang L, Zhang T, Gu HT, Dong BX, Shu MM, Hao CX, Zhang N, Chen XQ. Journal: Oncol Res Treat. 2016;39(1-2):45-52. doi: 10.1159/000442763. Epub 2016 Jan 22. PubMed |
| 9. | Low-Frequency Ultrasound Enhances Paclitaxel Efficacy in EMT6 Subcutaneous Tumors in Balb/c Mice. Author: Liu ZY, Weng CX, Chen W, Zhao HY, Li T. Journal: Oncol Res Treat. 2016;39(4):204-8. doi: 10.1159/000445314. Epub 2016 Mar 28. PubMed |
| 10. | C-Reactive Protein is a Prognostic Marker for Patients with Castration-Resistant Prostate Cancer. Author: Liao SG, Cheng HH, Lei Y. Journal: Oncol Res Treat. 2016;39(5):266-71. doi: 10.1159/000446098. Epub 2016 Apr 26. PubMed |
|
|
